Predictors of Treatment Failure in HIV-Positive Children Receiving Combination Antiretroviral Therapy: Cohort Data From Mozambique and Uganda
Author(s) -
Paola Costenaro,
Martina Penazzato,
Rebecca Lundin,
Giuliana Rossi,
William Massavon,
Deven Patel,
Sandra Monica Nabachwa,
Genny Franceschetto,
Erika Morelli,
Davide Bilardi,
Maria Nannyonga,
Andrea Atzori,
Maria L. Mastrogiacomo,
Antonio Mazza,
Giovanni Putoto,
Carlo Giaquinto
Publication year - 2014
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piu032
Subject(s) - medicine , lamivudine , efavirenz , zidovudine , stavudine , cart , nevirapine , hazard ratio , tuberculosis , incidence (geometry) , pediatrics , viral load , confidence interval , immunology , antiretroviral therapy , human immunodeficiency virus (hiv) , viral disease , hepatitis b virus , mechanical engineering , virus , optics , pathology , engineering , physics
Delays detecting treatment failure and switching to second-line combination antiretroviral therapy (cART) are often observed in human immunodeficiency virus (HIV)-infected children of low-middle-income countries (LMIC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom